Tumor immunology and immunotherapy: a journey I started from Hangzhou

J Zhejiang Univ Sci B. 2019 May;20(5):373-380. doi: 10.1631/jzus.B1900204.

Abstract

This short article is dedicated to the 90th Anniversary of the School of Life Sciences at Zhejiang University, China. Immunotherapy of cancer is currently a hot topic in the biomedical field, and a re-search focus of my laboratory is on developing new and effective combinatorial immunotherapeutic strategies for liver cancer. Of note, my interest in immunotherapy of cancer stems from the training as an undergraduate student at Hangzhou University, China, almost 40 years ago.

Keywords: Immunotherapy; Liver cancer; Tumor immunology; 90th Anniversary.

Publication types

  • Autobiography
  • Historical Article

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • China
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Immunologic Factors / therapeutic use*
  • Immunotherapy / history*
  • Immunotherapy / methods*
  • Liver / metabolism
  • Liver Neoplasms / immunology
  • Liver Neoplasms / therapy*
  • Mice
  • Oncogenes
  • Signal Transduction
  • Synaptophysin / metabolism
  • United States
  • Universities

Substances

  • Antineoplastic Agents
  • Immunologic Factors
  • SYP protein, human
  • Synaptophysin

Personal name as subject

  • Gen-sheng Feng